News|Articles|September 29, 2021
- Pharmaceutical Technology's In the Lab eNewsletter, October 2021
- Volume 16
- Issue 10
USP Publishes General Chapter 1220 of Analytical Procedure Life Cycle
Author(s)Pharmaceutical Technology Editors
USP is publishing the analytics-focused chapter, which considers validation activities, in advance of the official publication.
Advertisement
The United States Pharmacopeia announced on Sept, 24, 2021, that it is publishing the approved General Chapter <1220> “Analytical Procedure Life Cycle”. The new chapter considers the validation activities that occur throughout the life cycle of an analytical procedure.
This chapter is being published in advance of the official publication posting to allow stakeholders additional time for reading and understanding the new chapter. It will be incorporated into USP–NF 2022, Issue 1 on Nov. 1, 2021 and will become official on May 1, 2022.
The chapter can be accessed
Source:
Articles in this issue
about 4 years ago
Advancing Detection of Unknown Impuritiesabout 4 years ago
LabVantage Solutions Now Offers LabVantage Enterprise SaaSabout 4 years ago
Gyros Protein Technologies Announces New Titer Kitabout 4 years ago
CuriRx Launches CuriLytics Platformabout 4 years ago
In Vivo Falls Behind In Vitro for Adventitious Agent Testingabout 4 years ago
Vector Laboratories Closes $124 Million BuyoutNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
